TER.NASDAQTeradyne, INC

Form 4: Teradyne Director van Kralingen Receives Stock Grant

Sentiment:

SEC Form 4 Filing


Director Bridget A van Kralingen received 1,876 restricted stock units from Teradyne, Inc. on May 9, 2024.

Summary

  • On May 9, 2024, Bridget A van Kralingen, a director of Teradyne, Inc., acquired 1,876 shares of common stock in the form of restricted stock units (RSUs).
  • These RSUs were granted under the company's 2006 Equity and Cash Compensation Incentive Plan.
  • Each RSU represents the right to receive one share of Teradyne common stock.
  • The RSUs will vest in full on the earlier of May 9, 2025, or the date of the Issuer's 2025 Annual Meeting of Shareholders.
  • Following the transaction, van Kralingen directly owns 2,585 shares of Teradyne common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The stock grant is a standard practice and indicates confidence in the company's future, but it's not a major event.

Positives

  • The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing her to work towards the company's success.
  • The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain any specific forward-looking statements regarding Teradyne's future performance.

Industry Context

Stock grants to directors are a common practice in publicly traded companies to align their interests with those of shareholders and incentivize long-term value creation. This is a standard form 4 filing related to that practice.

Stakeholder Impact

  • The stock grant aligns the director's interests with those of shareholders, potentially leading to decisions that benefit the company's long-term value.
  • Employees may view the stock grant as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
05/09/2024Date of transaction: Bridget A van Kralingen acquired 1,876 restricted stock units.
05/09/2025Vesting date for the RSUs, or the date of the Issuer's 2025 Annual Meeting of Shareholders, whichever is earlier.
05/13/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.